Windtree Therapeutics plans to purchase up to $700 million in BNB, the fifth-largest cryptocurrency, to bolster its balance sheet. The Nasdaq-listed biotech firm is raising $520 million to facilitate these purchases after previously announcing an intent to acquire $200 million worth of BNB. They are partnering with the cryptocurrency exchange Kraken for asset custody. Windtree will secure funds through a $500 million equity line from an institutional investor and a $20 million stock-purchase agreement with Build and Build Corp. The CEO emphasized that stockholder approval is pending for this strategy, which is reminiscent of other companies such as Nano Labs, which recently disclosed a $1 billion BNB acquisition plan. The recent surge in BNB's value, reaching an all-time high of $808, has encouraged firms like Windtree to invest in digital assets to enhance stock performance.

Source đź”—